Ketamine for Pain

Overview: Ketamine is a versatile drug with various applications in medicine. At subanesthetic doses, it has shown potential as an alternative treatment option for chronic pain that is resistant to traditional approaches. Ketamine is thought to produce its pain-relieving effects by blocking N-methyl-D-aspartate (NMDA) receptors, which are glutamate receptors involved in transmitting messages related to pain, enhancing neural plasticity, and improving mood. However, further studies are needed to fully understand the safety and potential toxicity issues associated with the use of ketamine for chronic pain treatment. While ketamine shows promise in treating neuropathic pain, more research is needed to determine its efficacy for this purpose. 

‍

Exploring the Use of Ketamine for Pain Management

Ketamine was first synthesized in 1962 by American organic chemist Calvin Lee Stevens of the pharmaceutical laboratory Parke-Davis while he was searching for a safer alternative to phencyclidine (PCP). Two years later, psychopharmacology pioneer Ed Domino identified ketamine’s anesthetic properties when he administered doses of 1.0 - 2.0 mg/kg to 20 volunteers from a prison population, determining that the drug was worthy of further pharmacological and clinical investigation.

‍

Ketamine is a dissociative anesthetic drug that has versatile applications. It has a variety of applications in medicine, including as a general anesthetic for surgery, as a treatment for depression and other mental health disorders, and as an analgesic for pain management.

‍

Chronic pain is any pain that persists for more than three to six months. It can be caused by a variety of conditions, including injuries, surgeries, or medical conditions.

‍

Chronic neuropathic pain is a type of chronic pain that is caused by damage or dysfunction of the nerves that transmit pain signals from the body to the brain. Affecting 7–10% of the general population, chronic neuropathic pain is often described as a burning, tingling, or stabbing sensation and can be difficult to treat.

‍

Neuropathic pain typically results from disease, injury, infection, or limb loss and it can lead to unexpected and severe pain in response to ordinary environmental stimuli. Chronic neuropathic pain can be very challenging because it involves complex symptoms, has poor outcomes, and requires difficult treatment decisions. This can make it very burdensome for those who suffer from it.

‍

For the past 60 years, the management of chronic pain has been approached through trial and error, with opioids, non-steroidal anti-inflammatory drugs, anticonvulsants, and antidepressants being the primary treatments.

‍

At subanesthetic doses, ketamine has shown promising potential as an alternative treatment option for chronic pain that is resistant to traditional approaches. This has led to a surge of scientific interest in the compound, with ketamine increasingly being employed as an effective treatment for various chronic pain syndromes, particularly neuropathic pain conditions.

‍

When used in a controlled, therapeutic setting, ketamine has shown potential as an effective treatment for various types of pain, including chronic neuropathic pain, peripheral nerve injury, complex regional pain syndrome, chronic migraine, limb ischemia, fibromyalgia, spinal cord injury, and whiplash. 

‍

How Does Ketamine Treat Pain?

Ketamine is thought to produce its pain-relieving effects by blocking N-methyl-D-aspartate (NMDA) receptors, which are glutamate receptors located in spinal and supraspinal sites responsible for transmitting messages related to pain from damaged tissue. This blockade of NMDA receptors by ketamine can enhance anti-nociceptive systems, ultimately leading to a reduced detection of painful stimuli.

‍

In addition to its impact on NMDA receptors, ketamine also interacts with other receptor systems such as opioidergic, muscarinic, and monoaminergic receptors. While the contributions of these receptor systems to the effects of ketamine are not fully understood, they are believed to play a role in its overall impact on the body.

‍

Ketamine’s analgesic properties may also be mediated by its ability to temporarily enhance the brain’s ability to form new connections between neurons and to modify and adapt the brain’s structure and function in response to experience. This is known as neural plasticity. 

‍

Its growing popularity in scientific research can also be attributed, in part, to its ability to not interfere with patient functionality and its concurrent antidepressant effects. Its ability to improve mood and reduce anxiety may also help improve the experience of pain, though the exact mechanism is not yet fully understood 

‍

‍

Ketamine for Chronic Pain

In 2010, Dutch scientist Ingeborg Noppers and colleagues analyzed thirty-six randomized controlled trials (RCTs — the gold standard for evaluating the effectiveness of medical interventions — investigating ketamine's effect on chronic non-cancer pain, involving a total of 776 patients.

‍

In their review, titled Ketamine for the treatment of chronic non-cancer pain, the authors concluded that the administration of long-term intravenous administration of ketamine produces up to a 50% reduction in chronic pain that can last for up to several months.

‍

Despite these positive results, the authors concluded that further studies are needed to fully understand the safety and potential toxicity issues associated with the use of ketamine for chronic pain treatment. 

‍

Ketamine for Chronic Pain: Do Benefits Outweigh Risks?

Following this, a 2013 review of the relevant literature on the benefits and risks of ketamine for chronic pain found that ketamine can provide long-term pain relief for chronic pain, especially when it has a neuropathic component. However, the limited number of RCTs available makes it difficult to draw definitive conclusions.

‍

The authors found that ketamine can have side effects, such as CNS-related symptoms, cardiovascular stimulation, and liver injury, but that many doctors and patients feel that the benefits of ketamine outweigh the risks for specific patient populations.

‍

To confirm these ideas, more studies that compare ketamine to a placebo or other treatments are needed to prove that using ketamine for a long time can relieve pain without causing too many side effects.

‍

Limited Evidence for Ketamine Therapy in Neuropathic Pain? A Review

A review published in 2017 aimed to assess the available clinical evidence regarding ketamine infusion protocols for treating neuropathic pain and to call for further research into optimizing these protocols for specific conditions such as complex regional pain syndrome (CRPS), postherpetic neuralgia, traumatic spinal cord injury, and phantom limb pain, reported contrasting results.

‍

The review highlighted the limited evidence available to guide ketamine infusion therapy for neuropathic pain and emphasized the need for well-designed comparative studies to analyze the use of different ketamine infusion protocols for specific neuropathic pain conditions. According to the authors, identifying the factors associated with better outcomes for neuropathic pain treatment with ketamine infusion therapy can only be achieved through further well-designed clinical trials.

‍

It is crucial to keep in mind that while ketamine shows promise in treating neuropathic pain, more research is needed to determine its safety and efficacy for this purpose.

‍

Use of Ketamine in Emergency and Perioperative Hospital Settings

In 2006, a review examined the effectiveness and safety of giving ketamine to patients before or after surgery to treat acute pain. The review found that adverse effects were either moderate or nonexistent, which led to a reduction in postoperative nausea and vomiting.

‍

Additionally, the review discovered that 73% of the RCTs included in the review reported that ketamine, when given in subanesthetic doses before or after surgery, reduced pain intensity and patient reliance on opioids.

‍

A more recent review by professors Eun Nam Lee and Jae Hoon Lee explored the use of ketamine as an alternative to opioid painkillers for patients in an emergency department or pre-hospital setting. 

‍

They found that ketamine, which activates respiratory effort, was either as effective or more effective than opioids like fentanyl and morphine in reducing pain levels. In addition, ketamine was associated with fewer cardiopulmonary side effects and had no significant side effects of its own.

‍

The findings of these studies should be interpreted with caution due to the limitations inherent in the methodology and sample size.

‍

Ketamine for Cancer Pain

Ketamine is sometimes used alongside opioid painkillers in the treatment of cancer pain, but evidence of its efficacy is limited. However, anecdotal reports and case studies suggest that ketamine can be a useful tool in managing treatment-resistant cancer pain.

‍

Researchers at Leiden University Medical Center analyzed sixteen open-label studies and four RCTs of ketamine for cancer pain. The open-label studies found that ketamine reduced opioid use and effectively alleviated pain symptoms in terminally ill cancer patients. However, the RCTs did not show clinically relevant benefits.

‍

Despite these mixed results, experimental evidence suggests that ketamine can enhance pain inhibition and reduce pain hypersensitivity, resulting in higher levels of patient satisfaction. Further research is needed to understand why RCTs have not shown ketamine to be effective for cancer pain.

‍

Ketamine and Pain Treatment: A Summary of the Evidence

Ketamine has shown promise in reducing chronic pain, particularly in cases with a neuropathic component. However, further research is needed to determine its safety and efficacy in treating chronic pain, as well as to optimize infusion protocols for specific conditions.

‍

Ketamine may also be a useful alternative to opioids in emergency and perioperative hospital settings, and anecdotal evidence suggests it may be effective in managing treatment-resistant cancer pain. However, the limited number of studies and mixed results highlight the need for further research to fully understand its potential benefits and risks.

‍

Overall, the use of ketamine in therapeutic settings has shown potential in managing various types of pain, but further studies are needed to determine the long-term benefits and risks of ketamine infusion therapy.